Stay updated on Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the usual study record content. This signals an access restriction or server issue impacting the NCT03528408 page.
    Difference
    19%
    Check dated 2026-09-19T21:51:16.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6, indicating a software revision of the site. This is a maintenance update and does not change the displayed study details or workflow.
    Difference
    0.1%
    Check dated 2026-08-29T19:43:56.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Revision label on the page updated to v3.6.5, replacing the previous v3.6.4. This signals a minor update to the study record metadata rather than changes to study details.
    Difference
    0.1%
    Check dated 2026-08-08T18:25:37.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4 in the page footer, indicating a small site update with no changes to study details or navigation.
    Difference
    0.1%
    Check dated 2026-07-25T10:25:03.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    The page now shows revision: v3.6.3, replacing the previous v3.6.2. This indicates a minor metadata/format update to the page rather than a substantive change to content.
    Difference
    0.1%
    Check dated 2026-07-03T23:55:08.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a refreshed or corrected version of the study record.
    Difference
    0.1%
    Check dated 2026-06-26T19:38:14.000Z thumbnail image

Stay in the know with updates to Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page.